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Abstract 
In this data article, we describe the enzymatic kinetic resolution of a series of racemic mixed 
phosphonoacetates, which were successfully prepared from methyl bis(2,2,2-
trifluoroethyl)phosphonoacetate (Still-Gennari reagent) by alcoholysis with σ-symmetrical secondary 
alcohols in the presence of 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU). Porcine liver esterase (PLE)-
catalyzed kinetic resolution of some of these racemic mixed phosphonoacetates proceeded in a highly 
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Chiral Horner-Wadsworth-Emmons (HWE) reagents are extremely useful for asymmetric olefination of 
prochiral aldehydes or ketones [1–4]. However, most of these chiral HWE reagents are restricted to the 
compounds with non-stereogenic phosphorus atom, which are more easily available than P-stereogenic 
HWE reagents. We have already reported the facile synthesis of two kinds of chiral P-stereogenic 
phosphonoacetates (>99% ee) by porcine liver esterase (PLE)-catalyzed kinetic resolution of the 
corresponding racemic mixed phosphonoacetates [5]. To verify the generality of this synthetic method, 
a series of racemic mixed phosphonoacetates were synthesized and subjected to enzymatic hydrolysis in 
the presence of PLE, which has been widely used as a practical biocatalyst in organic synthesis. 
Nucleophilic substitution of symmetrical secondary alcohols 2a–j at the phosphorus center of methyl 
bis(2,2,2-trifluoroethyl)phosphonoacetate (Still-Gennari reagent, 1) [6,7] furnished racemic mixed 
phosphonoacetates rac-3a–j in 66–81% yields [5,8,9]. Enzymatic hydrolysis of rac-3a–j using PLE gave 
the corresponding carboxylic acids 4a–j and allowed recovery of unreacted esters 3a–j. As a result, 
racemic mixed phosphonoacetates rac-3a and rac-3d afforded the optically enriched P-stereogenic 




2.1 Materials and methods 
 
All melting points were determined on a Yanagimoto micro melting point apparatus and uncorrected. IR 
spectra were obtained using a JASCO FT/IR-420 IR Fourier transform spectrometer. 1H-NMR (400 MHz) 
and 13C-NMR (75 MHz) spectra were recorded on JEOL JNM-AL400, Bruker AV400N, and JEOL JNM-
AL300 spectrometers, respectively. Chemical shifts are given in δ values (parts per million) using 
tetramethylsilane (TMS) as an internal standard. ESI-MS were recorded on a Waters LCT Premier 
spectrometer. Elemental analyses were performed using a Yanaco CHN CORDER MT-5. Optical rotations 
were recorded on JASCO digital polarimeter DIP-370. All reactions were monitored by TLC employing 
0.25 mm silica gel plates (Merck 5715; 60 F254). Column chromatography was carried out on silica gel 
(Kanto Chemical 60N; 63–210 μm or Nacalai Tesque 75SL-II-PREP; 75 μm). Chiral-stationary-phase HPLC 
analyses were performed using a JASCO PU-980 apparatus equipped with a JASCO UV/VIS detector. The 
absolute configurations of 3a–j and 4a–j were not determined. All reagents were used as purchased. 
 
2.2 General procedure for the synthesis of racemic phosphonoacetates rac-3a–j 
 
DBU (2.24 mL, 15.00 mmol) was added to a solution of methyl bis(2,2,2-
trifluoroethyl)phosphonoacetate (1) (1.06 mL, 5.00 mmol) and 3-pentanol (2a) (1.62 mL, 15.00 mmol) in 
anhydrous THF (25 mL) containing molecular sieves 3A (powder, 1.59 g) at room temperature under 
argon. After being stirred at room temperature for 15 h, the reaction mixture was treated with 5% HCl 
(20 mL) and extracted with AcOEt (100 mL x 3). The extract was washed with brine (30 mL) and dried 
over anhydrous MgSO4. The organic layer was evaporated in vacuo to afford an oily residue, which was 
purified by chromatography on silica gel (Kanto Chemical 60N) column [n-hexane–AcOEt (3:1)] to give 




Scheme 1.  Synthesis of racemic phosphonoacetates rac-3a–j. 
 
2.3 General procedure for the PLE-catalyzed kinetic resolution of racemic phosphonoacetates rac-3a–j  
 
PLE (Sigma; E-2884, 240 units, 800 units/mmol) was added to a stirred solution of methyl 2-[(pentan-3-
yloxy)(2,2,2-trifluoroethoxy)phosphoryl]acetate (rac-3a) (91.9 mg, 0.30 mmol) in 1/15 M phosphate 
buffer (pH 7.4, 9 mL) and acetone (1 mL) at room temperature. After being stirred at room temperature 
for 1.5 h, the reaction mixture was treated with 5% HCl (5 mL) and then extracted with AcOEt (40 mL x 
5). The extract was washed with brine (20 mL) and dried over anhydrous MgSO4. The organic layer was 
evaporated in vacuo to afford an oily residue, which was purified by chromatography on silica gel 
(Nacalai Tesque 75SL-II-PREP) column [CHCl3–MeOH (50:1)] to give (S*)-4a (53.3 mg, 61%) as a white 
powder and (R*)-3a (35.5 mg, 39%, 99% ee) as a colorless oil. To the solution of (S*)-4a in MeOH (1 mL) 
and benzene (3.5 mL) was added an excess amount of TMSCHN2 (2.0 M solution in n-hexane, ca. 0.3 mL, 
ca. 0.6 mmol). After being stirred at room temperature for 30 min, the reaction mixture was evaporated 
in vacuo to afford a crude product, which was purified by chromatography on a silica gel (Kanto 




Scheme 2.  PLE-catalyzed kinetic resolution of racemic phosphonoacetates rac-3a–j. 
 
2.4 Analytical and spectral data obtained for compounds 3a–j 
 
Methyl 2-[(Pentan-3-yloxy)(2,2,2-trifluoroethoxy)phosphoryl]acetate (3a) 
Colorless oil. 
99% ee; [α]D18 +10.0 (c 1.00, MeOH). 
IR (neat): 2974, 1745, 1263, 1173, 1093, 1001 cm-1 
1H NMR (400 MHz, CDCl3): δ 0.93 (3H, t, 3JH,H = 7.3 Hz), 0.95 (3H, t, 3JH,H = 7.3 Hz), 1.60–1.75 (4H, m), 3.05 
(2H, d, 2JH,P = 21.7 Hz), 3.75 (3H, s), 4.35–4.55 (3H, m). 
13C NMR (75 MHz, CDCl3): δ 9.2 (s), 9.3 (s), 27.6 (d, 3JC,P = 3.7 Hz), 27.8 (d, 3JC,P = 4.4 Hz), 34.5 (d, 1JC,P = 
140.8 Hz), 52.7 (s), 63.1 (qd, 2JC,F = 37.4 Hz, 2JC,P = 5.0 Hz), 82.4 (d, 2JC,P = 7.5 Hz), 123.2 (qd, 1JC,F = 277.4 
Hz, 3JC,P = 8.7 Hz), 166.2 (d, 2JC,P = 5.0 Hz). 
HRMS (ESI): m/z [M + H]+ calcd for C10H19F3O5P: 307.0922; found: 307.0930. 
Anal. calcd for C10H18F3O5P: C, 39.22; H, 5.92. Found: C, 39.05; H, 5.97%. 
 
Methyl 2-[(Heptan-4-yloxy)(2,2,2-trifluoroethoxy)phosphoryl]acetate (3b) 
Colorless oil. 
IR (neat): 2962, 1745, 1265, 1171, 1093, 1007 cm-1. 
1H NMR (400 MHz, CDCl3): δ 0.92 (3H, t, 3JH,H = 7.3 Hz), 0.93 (3H, t, 3JH,H = 7.3 Hz), 1.28–1.50 (4H, m), 
1.52–1.71 (4H, m), 3.03 (2H, d, 2JH,P = 21.5 Hz), 3.75 (3H, s), 4.34–4.61 (3H, m). 
13C NMR (75 MHz, CDCl3): δ 13.89 (s), 13.92 (s), 18.2 (s), 18.3 (s), 34.5 (d, 1JC,P = 141.4 Hz), 37.3 (d, 3JC,P = 
3.7 Hz), 37.4 (d, 3JC,P = 4.4 Hz), 52.7 (s), 63.1 (qd, 2JC,F = 37.4 Hz, 2JC,P = 4.7 Hz), 79.8 (d, 2JC,P = 7.5 Hz), 123.0 
(qd, 1JC,F = 277.6 Hz, 3JC,P = 8.7 Hz), 166.0 (d, 2JC,P = 5.6 Hz). 
HRMS (ESI): m/z [M + H]+ calcd for C12H23F3O5P: 335.1235; found: 335.1219. 
Anal. calcd for C12H22F3O5P: C, 43.12; H, 6.63. Found: C, 42.89; H, 6.54%. 
 
Methyl 2-[(Nonan-5-yloxy)(2,2,2-trifluoroethoxy)phosphoryl]acetate (3c) 
Colorless oil. 
IR (neat): 2958, 1745, 1265, 1173, 1093, 1009 cm-1. 
1H NMR (400 MHz, CDCl3): δ 0.83–0.96 (6H, m), 1.22–1.43 (8H, m), 1.54–1.72 (4H, m), 3.04 (2H, d, 2JH,P = 
21.5 Hz), 3.75 (3H, s), 4.35–4.60 (3H, m). 
13C NMR (75 MHz, CDCl3): δ 13.96 (s), 14.02 (s), 22.6 (s), 27.1 (s), 27.2 (s), 34.5 (d, 1JC,P = 141.4 Hz), 34.9 
(d, 3JC,P = 3.7 Hz), 35.0 (d, 3JC,P = 4.4 Hz), 52.7 (s), 63.1 (qd, 2JC,F = 37.4 Hz, 2JC,P = 4.4 Hz), 80.3 (d, 2JC,P = 8.1 
Hz), 123.1 (qd, 1JC,F = 277.6 Hz, 3JC,P = 8.7 Hz), 166.0 (d, 2JC,P = 5.0 Hz). 
HRMS (ESI): m/z [M + H]+ calcd for C14H27F3O5P: 363.1548; found: 363.1556. 
Anal. calcd for C14H26F3O5P: C, 46.41; H, 7.23. Found: C, 46.13; H, 7.17%. 
 
Methyl 2-[(2,2,2-Trifluoroethoxy)(undecan-6-yloxy)phosphoryl]acetate (3d) 
Colorless oil. 
>99% ee; [α]D15 +7.5 (c 0.75, MeOH). 
IR (neat): 2956, 2935, 1747, 1265, 1173, 1122, 1093 cm-1. 
1H NMR (400 MHz, CDCl3): δ 0.89 (6H, t, 3JH,H = 6.7 Hz), 1.16–1.46 (12H, m), 1.52–1.72 (4H, m), 3.03 (2H, 
d, 2JH,P = 21.5 Hz), 3.75 (3H, s), 4.35–4.59 (3H, m). 
13C NMR (75 MHz, CDCl3): δ 13.96 (s), 14.02 (s), 22.5 (s), 24.55 (s), 24.60 (s), 31.6 (s), 34.5 (d, 1JC,P = 140.8 
Hz), 35.1 (d, 3JC,P = 3.7 Hz), 35.2 (d, 3JC,P = 4.4 Hz), 63.0 (qd, 2JC,F = 37.4 Hz, 2JC,P = 4.7 Hz), 80.3 (d, 2JC,P = 7.5 
Hz), 122.9 (qd, 1JC,F = 277.6 Hz, 3JC,P = 8.7 Hz), 165.9 (d, 2JC,P = 5.0 Hz). 
HRMS (ESI): m/z [M + H]+ calcd for C16H31F3O5P: 391.1861; found: 391.1865. 
Anal. calcd for C16H30F3O5P: C, 49.23; H, 7.75. Found: C, 49.03; H, 7.63%. 
 
Methyl 2-[(Tridecan-7-yloxy)(2,2,2-trifluoroethoxy)phosphoryl]acetate (3e) 
Colorless oil. 
IR (neat): 2931, 1747, 1267, 1171, 1093, 1003 cm-1. 
1H NMR (400 MHz, CDCl3): δ 0.88 (6H, t, 3JH,H = 6.5 Hz), 1.17–1.47 (16H, m), 1.52–1.71 (4H, m), 3.03 (2H, 
d, 2JH,P = 21.5 Hz), 3.75 (3H, s), 4.35–4.59 (3H, m). 
13C NMR (75 MHz, CDCl3): δ 14.1 (s), 22.69 (s), 22.73 (s), 24.98 (s), 25.03 (s), 29.3 (s), 31.8 (s), 31.9 (s), 
34.5 (d, 1JC,P = 140.8 Hz), 35.3 (d, 3JC,P = 3.7 Hz), 35.4 (d, 3JC,P = 4.4 Hz), 52.7 (s), 63.1 (qd, 2JC,F = 37.6 Hz, 
2JC,P = 4.7 Hz), 80.3 (d, 2JC,P = 7.5 Hz), 123.1 (qd, 1JC,F = 277.4 Hz, 3JC,P = 8.7 Hz), 166.0 (d, 2JC,P = 5.0 Hz). 
HRMS (ESI): m/z [M + H]+ calcd for C18H35F3O5P: 419.2174; found: 419.2173. 
Anal. calcd for C18H34F3O5P: C, 51.67; H, 8.19. Found: C, 51.51; H, 8.07%. 
 
Methyl 2-[(Pentadecan-8-yloxy)(2,2,2-trifluoroethoxy)phosphoryl]acetate (3f) 
Colorless oil. 
IR (neat): 2929, 1747, 1267, 1171, 1093, 1005 cm-1. 
1H NMR (400 MHz, CDCl3): δ 0.88 (6H, t, 3JH,H = 6.6 Hz), 1.18–1.44 (20H, m), 1.51–1.71 (4H, m), 3.03 (2H, 
d, 2JH,P = 21.5 Hz), 3.75 (3H, s), 4.34–4.59 (3H, m). 
13C NMR (75 MHz, CDCl3): δ 14.1 (s), 22.7 (s), 24.96 (s), 25.02 (s), 29.2 (s), 29.3 (s), 29.5 (s), 31.8 (s), 31.9 
(s), 34.5 (d, 1JC,P = 140.8 Hz), 35.2 (d, 3JC,P = 3.7 Hz), 35.5 (d, 3JC,P = 4.4 Hz), 52.7 (s), 63.1 (qd, 2JC,F = 37.4 Hz, 
2JC,P = 5.0 Hz), 80.3 (d, 2JC,P = 8.1 Hz), 123.0 (qd, 1JC,F = 277.6 Hz, 3JC,P = 8.7 Hz), 166.0 (d, 2JC,P = 5.6 Hz). 
HRMS (ESI): m/z [M + H]+ calcd for C20H39F3O5P: 447.2487; found: 447.2488. 
Anal. calcd for C20H38F3O5P: C, 53.80; H, 8.58. Found: C, 53.71; H, 8.83%. 
 
Methyl 2-[(Cyclopentyloxy)(2,2,2-trifluoroethoxy)phosphoryl]acetate (3g) 
Colorless oil. 
IR (neat): 2964, 1745, 1265, 1173, 1093, 1011 cm-1. 
1H NMR (400 MHz, CDCl3): δ 1.50–1.69 (3H, m), 1.69–1.95 (5H, m), 3.03 (2H, d, 2JH,P = 21.5 Hz), 3.75 (3H, 
s), 4.40 (1H, doublet of quintets, 2JH,H = 12.2 Hz, 3JH,F = 3JH,P = 8.3 Hz), 4.47 (1H, doublet of quintets, 2JH,H = 
12.2 Hz, 3JH,F = 3JH,P = 8.3 Hz), 4.99–5.11 (1H, m). 
13C NMR (75 MHz, CDCl3): δ 22.96 (s), 22.99 (s), 34.06 (d, 3JC,P = 4.4 Hz), 34.15 (d, 3JC,P = 5.0 Hz), 34.4 (d, 
1JC,P = 140.1 Hz), 52.7 (s), 62.8 (qd, 2JC,F = 37.7 Hz, 2JC,P = 5.0 Hz), 81.3 (d, 2JC,P = 7.5 Hz), 122.8 (qd, 1JC,F = 
277.8 Hz, 3JC,P = 8.5 Hz), 165.9 (d, 2JC,P = 5.6 Hz). 
HRMS (ESI): m/z [M + H]+ calcd for C10H17F3O5P: 305.0766; found: 305.0777. 
Anal. calcd for C10H16F3O5P: C, 39.48; H, 5.30. Found: C, 39.25; H, 5.11%. 
 
Methyl 2-[(Cyclohexyloxy)(2,2,2-trifluoroethoxy)phosphoryl]acetate (3h) 
Colorless oil. 
IR (neat): 2941, 1745, 1267, 1173, 1093, 1012 cm-1. 
1H NMR (400 MHz, CDCl3): δ 1.19–1.43 (3H, m), 1.45–1.65 (3H, m), 1.68–1.82 (2H, m), 1.84–2.01 (2H, m), 
3.05 (2H, d, 2JH,P = 21.5 Hz), 3.75 (3H, s), 4.32–4.64 (3H, m). 
13C NMR (75 MHz, CDCl3): δ 23.4 (s), 25.0 (s), 33.45 (d, 3JC,P = 5.0 Hz), 33.46 (d, 3JC,P = 3.7 Hz), 34.5 (d, 1JC,P 
= 140.1 Hz), 52.7 (s), 62.7 (qd, 2JC,F = 37.6 Hz, 2JC,P = 5.0 Hz), 77.6 (d, 2JC,P = 1.3 Hz), 122.9 (qd, 1JC,F = 277.6 
Hz, 3JC,P = 8.4 Hz), 165.9 (d, 2JC,P = 5.0 Hz). 
HRMS (ESI): m/z [M + H]+ calcd for C11H19F3O5P: 319.0922; found: 319.0923. 
Anal. calcd for C11H18F3O5P: C, 41.52; H, 5.70. Found: C, 41.52; H, 5.72%. 
 
Methyl 2-[(Cycloheptyloxy)(2,2,2-trifluoroethoxy)phosphoryl]acetate (3i) 
Colorless oil. 
IR (neat): 2935, 1745, 1263, 1171, 1093, 991 cm-1. 
1H NMR (400 MHz, CDCl3): δ 1.35–1.49 (2H, m), 1.51–1.74 (6H, m), 1.74–1.88 (2H, m), 1.92–2.05 (2H, m), 
3.03 (2H, d, 2JH,P = 21.5 Hz), 3.75 (3H, s), 4.40 (1H, doublet of quintet, 2JH,H = 12.1 Hz, 3JH,F = 3JH,P = 8.2 Hz), 
4.46 (1H, doublet of quintet, 2JH,H = 12.1 Hz, 3JH,F = 3JH,P = 8.3 Hz), 4.68–4.80 (1H, m). 
13C NMR (75 MHz, CDCl3): δ 22.18 (s), 22.22 (s), 28.06 (s), 28.08 (s), 34.5 (d, 1JC,P = 140.1 Hz), 35.7 (d, 3JC,P 
= 3.1 Hz), 35.8 (d, 3JC,P = 5.0 Hz), 52.7 (s), 62.8 (qd, 2JC,F = 37.4 Hz, 2JC,P = 5.0 Hz), 80.1 (d, 2JC,P = 6.9 Hz), 
123.1 (qd, 1JC,F = 277.5 Hz, 3JC,P = 8.4 Hz), 166.0 (d, 2JC,P = 5.0 Hz). 
HRMS (ESI): m/z [M + H]+ calcd for C12H21F3O5P: 333.1079; found: 333.1077. 
Anal. calcd for C12H20F3O5P: C, 43.38; H, 6.07. Found: C, 43.58; H, 6.24%. 
 
Methyl 2-[(Cyclooctyloxy)(2,2,2-trifluoroethoxy)phosphoryl]acetate (3j) 
Colorless oil. 
IR (neat): 2927, 1745, 1265, 1171, 1093, 1002 cm-1. 
1H NMR (400 MHz, CDCl3): δ 1.40–1.80 (10H, m), 1.80–2.01 (4H, m), 3.03 (2H, d, 2JH,P = 21.5 Hz), 3.75 (3H, 
s), 4.40 (1H, doublet of quintet, 2JH,H = 12.2 Hz, 3JH,F = 3JH,P = 8.2 Hz), 4.47 (1H, doublet of quintet, 2JH,H = 
12.2 Hz, 3JH,F = 3JH,P = 8.3 Hz), 4.67–4.81 (1H, m). 
13C NMR (75 MHz, CDCl3): δ 22.15 (s), 22.16 (s), 25.0 (s), 27.22 (s), 27.24 (s), 32.7 (d, 3JC,P = 3.1 Hz), 32.8 
(d, 3JC,P = 4.4 Hz), 34.5 (d, 1JC,P = 140.1 Hz), 52.7 (s), 62.8 (qd, 2JC,F = 37.6 Hz, 2JC,P = 5.0 Hz), 80.2 (d, 2JC,P = 
7.5 Hz), 123.0 (qd, 1JC,F = 277.6 Hz, 3JC,P = 8.7 Hz), 166.0 (d, 2JC,P = 5.0 Hz). 
HRMS (ESI): m/z [M + H]+ calcd for C13H23F3O5P: 347.1235; found: 347.1231. 
Anal. calcd for C13H22F3O5P: C, 45.09; H, 6.40. Found: C, 45.10; H, 6.27%. 
 
2.5 Analytical and spectral data obtained for compounds 4a–j 
 
2-[(Pentan-3-yloxy)(2,2,2-trifluoroethoxy)phosphoryl]acetic Acid (4a) 
Colorless plates; mp 46.0–47.0 °C (Et2O–n-hexane). 
IR (KBr): 2978, 1716, 1290, 1182, 1095, 1009 cm-1 
1H NMR (400 MHz, CDCl3): δ 0.93 (3H, t, 3JH,H = 7.3 Hz), 0.94 (3H, t, 3JH,H = 7.4 Hz), 1.59–1.77 (4H, m), 
2.99–3.17 (2H, m), 4.36–4.74 (3H, m), 8.53 (1H, br s). 
13C NMR (75 MHz, CDCl3): δ 9.1 (s), 9.2 (s), 27.5 (d, 3JC,P = 3.7 Hz), 27.6 (d, 3JC,P = 4.4 Hz), 34.3 (d, 1JC,P = 
142.0 Hz), 63.6 (qd, 2JC,F = 37.6 Hz, 2JC,P = 5.0 Hz), 83.1 (d, 2JC,P = 8.1 Hz), 123.0 (qd, 1JC,F = 277.4 Hz, 3JC,P = 
8.7 Hz), 167.6 (d, 2JC,P = 4.4 Hz). 
HRMS (ESI): m/z [M + H]+ calcd for C9H17F3O5P: 293.0766; found: 293.0745. 
Anal. calcd for C9H16F3O5P: C, 37.00; H, 5.52. Found: C, 36.96; H, 5.29%. 
 
2-[(Heptan-4-yloxy)(2,2,2-trifluoroethoxy)phosphoryl]acetic Acid (4b) 
Colorless oil. 
IR (neat): 2964, 2877, 1734, 1292, 1232, 1174, 1095, 1012 cm-1. 
1H NMR (400 MHz, CDCl3): δ 0.919 (3H, t, 3JH,H = 7.2 Hz), 0.922 (3H, t, 3JH,H = 7.3 Hz), 1.28–1.50 (4H, m), 
1.51–1.73 (4H, m), 3.06 (2H, d, 2JH,P = 21.5 Hz), 4.38–4.70 (3H, m), 10.16 (1H, br s). 
13C NMR (75 MHz, CDCl3): δ 13.9 (s), 18.2 (s), 18.3 (s), 34.4 (d, 1JC,P = 142.0 Hz), 37.3 (d, 3JC,P = 3.7 Hz), 
37.4 (d, 3JC,P = 4.4 Hz), 63.7 (qd, 2JC,F = 37.5 Hz, 2JC,P = 4.7 Hz), 80.6 (d, 2JC,P = 8.1 Hz), 123.0 (qd, 1JC,F = 277.4 
Hz, 3JC,P = 8.7 Hz), 167.6 (d, 2JC,P = 4.4 Hz). 
HRMS (ESI): m/z [M + H]+ calcd for C11H21F3O5P: 321.1079; found: 321.1080. 
Anal. calcd for C11H20F3O5P: C, 41.26; H, 6.29. Found: C, 40.96; H, 6.00%. 
 
2-[(Nonan-5-yloxy)(2,2,2-trifluoroethoxy)phosphoryl]acetic Acid (4c) 
Colorless oil. 
IR (neat): 2960, 2873, 1734, 1292, 1232, 1174, 1095, 1014 cm-1. 
1H NMR (400 MHz, CDCl3): δ 0.90 (6H, t, 3JH,H = 6.6 Hz), 1.23–1.44 (8H, m), 1.55–1.73 (4H, m), 3.06 (2H, d, 
2JH,P = 20.3 Hz), 4.38–4.72 (3H, m), 10.00 (1H, br s). 
13C NMR (75 MHz, CDCl3): δ 13.90 (s), 13.92 (s), 22.51 (s), 22.52 (s), 27.0 (s), 34.5 (d, 1JC,P = 141.4 Hz), 
34.76 (d, 3JC,P = 4.4 Hz), 34.83 (d, 3JC,P = 4.4 Hz), 63.6 (qd, 2JC,F = 37.6 Hz, 2JC,P = 4.4 Hz), 80.9 (d, 2JC,P = 8.1 
Hz), 122.9 (qd, 1JC,F = 277.4 Hz, 3JC,P = 8.7 Hz), 167.5 (d, 2JC,P = 3.7 Hz). 
HRMS (ESI): m/z [M + H]+ calcd for C13H25F3O5P: 349.1392; found: 349.1408. 
Anal. calcd for C13H24F3O5P: C, 44.83; H, 6.95. Found: C, 44.89; H, 6.79%. 
 
2-[(2,2,2-Trifluoroethoxy)(undecan-6-yloxy)phosphoryl]acetic Acid (4d) 
Colorless oil. 
IR (neat): 2935, 2864, 1734, 1292, 1234, 1174, 1095, 1012 cm-1. 
1H NMR (400 MHz, CDCl3): δ 0.89 (6H, t, 3JH,H = 6.7 Hz), 1.20–1.44 (12H, m), 1.54–1.71 (4H, m), 3.03 (1H, 
dd, 2JH,P = 22.6 Hz, 2JH,H = 15.0 Hz), 3.06 (1H, dd, 2JH,P = 20.7 Hz, 2JH,H = 15.0 Hz), 4.38–4.68 (3H, m), 5.93 
(1H, br s). 
13C NMR (75 MHz, CDCl3): δ 13.97 (s), 14.01 (s), 22.5 (s), 24.6 (s), 31.65 (s), 31.68 (s), 34.4 (d, 1JC,P = 142.0 
Hz), 35.06 (d, 3JC,P = 3.7 Hz), 35.15 (d, 3JC,P = 4.4 Hz), 63.7 (qd, 2JC,F = 37.6 Hz, 2JC,P = 4.4 Hz), 81.0 (d, 2JC,P = 
7.5 Hz), 122.9 (qd, 1JC,F = 277.4 Hz, 3JC,P = 8.7 Hz), 167.6 (d, 2JC,P = 4.4 Hz). 
HRMS (ESI): m/z [M + H]+ calcd for C15H29F3O5P: 377.1705; found: 377.1718. 
Anal. calcd for C15H28F3O5P: C, 47.87; H, 7.50. Found: C, 47.70; H, 7.48%. 
 
2-[(Tridecan-7-yloxy)(2,2,2-trifluoroethoxy)phosphoryl]acetic Acid (4e) 
Colorless oil. 
IR (neat): 2931, 2860, 1734, 1292, 1234, 1174, 1095, 1009 cm-1. 
1H NMR (400 MHz, CDCl3): δ 0.88 (6H, t, 3JH,H = 6.5 Hz), 1.19–1.49 (16H, m), 1.54–1.74 (4H, m), 3.05 (2H, 
d, 2JH,P = 21.7 Hz), 4.38–4.70 (3H, m), 8.50 (1H, br s). 
13C NMR (75 MHz, CDCl3): δ 14.1 (s), 22.61 (s), 22.63 (s), 24.9 (s), 29.2 (s), 31.7 (s), 34.4 (d, 1JC,P = 142.0 
Hz), 35.1 (d, 3JC,P = 3.7 Hz), 35.2 (d, 3JC,P = 4.4 Hz), 63.6 (qd, 2JC,F = 37.6 Hz, 2JC,P = 4.4 Hz), 80.9 (d, 2JC,P = 8.1 
Hz), 122.9 (qd, 1JC,F = 277.6 Hz, 3JC,P = 8.7 Hz), 167.6 (d, 2JC,P = 4.4 Hz). 
HRMS (ESI): m/z [M + H]+ calcd for C17H33F3O5P: 405.2018; found: 405.1994. 
Anal. calcd for C17H32F3O5P: C, 50.49; H, 7.98. Found: C, 50.57; H, 7.93%. 
 
2-[(Pentadecan-8-yloxy)(2,2,2-trifluoroethoxy)phosphoryl]acetic Acid (4f) 
Colorless oil. 
IR (neat): 2929, 2858, 1734, 1292, 1232, 1174, 1095, 1009 cm-1. 
1H NMR (400 MHz, CDCl3): δ 0.88 (6H, t, 3JH,H = 6.7 Hz), 1.18–1.45 (20H, m), 1.53–1.73 (4H, m), 3.05 (2H, 
d, 2JH,P = 21.7 Hz), 4.39–4.69 (3H, m), 8.16 (1H, br s). 
13C NMR (75 MHz, CDCl3): δ 14.1 (s), 22.7 (s), 24.9 (s), 29.2 (s), 29.4 (s), 31.78 (s), 31.82 (s), 34.5 (d, 1JC,P = 
141.4 Hz), 35.0 (d, 3JC,P = 3.7 Hz), 35.1 (d, 3JC,P = 4.4 Hz), 63.6 (qd, 2JC,F = 37.5 Hz, 2JC,P = 4.7 Hz), 81.0 (d, 2JC,P 
= 7.5 Hz), 122.9 (qd, 1JC,F = 277.6 Hz, 3JC,P = 8.7 Hz), 167.5 (d, 2JC,P = 3.7 Hz). 
HRMS (ESI): m/z [M + H]+ calcd for C19H37F3O5P: 433.2331; found: 433.2349. 
Anal. calcd for C19H36F3O5P: C, 52.77; H, 8.39. Found: C, 52.63; H, 8.38%. 
 
2-[(Cyclopentyloxy)(2,2,2-trifluoroethoxy)phosphoryl]acetic Acid (4g) 
Colorless plates; mp 39.5–40.5 °C (Et2O–n-hexane). 
IR (KBr): 2974, 1718, 1292, 1230, 1176, 1095, 1012 cm-1. 
1H NMR (400 MHz, CDCl3): δ 1.54–1.96 (8H, m), 3.05 (2H, d, 2JH,P = 21.7 Hz), 4.44 (1H, doublet of quintets, 
2JH,H = 12.4 Hz, 3JH,F = 3JH,P = 8.2 Hz), 4.60 (1H, doublet of quintets, 2JH,H = 12.4 Hz, 3JH,F = 3JH,P = 8.4 Hz), 5.04–
5.13 (1H, m), 9.34 (1H, br s). 
13C NMR (75 MHz, CDCl3): δ 22.96 (s), 22.99 (s), 34.0 (d, 3JC,P = 4.4 Hz), 34.1 (d, 3JC,P = 5.6 Hz), 34.3 (d, 1JC,P 
= 140.1 Hz), 63.3 (qd, 2JC,F = 37.6 Hz, 2JC,P = 5.0 Hz), 82.0 (d, 2JC,P = 7.5 Hz), 122.9 (qd, 1JC,F = 277.5 Hz, 3JC,P = 
8.4 Hz), 167.5 (d, 2JC,P = 4.4 Hz). 
HRMS (ESI): m/z [M + H]+ calcd for C9H15F3O5P: 291.0609; found: 291.0605. 
Anal. calcd for C9H14F3O5P: C, 37.25; H, 4.86. Found: C, 37.17; H, 4.83%. 
 
2-[(Cyclohexyloxy)(2,2,2-trifluoroethoxy)phosphoryl]acetic Acid (4h) 
Colorless plates; mp 49.5–50.5 °C (Et2O–n-hexane). 
IR (KBr): 2945, 2868, 2576, 1730, 1308, 1219, 1180, 1093, 1014 cm-1. 
1H NMR (400 MHz, CDCl3): δ 1.20–1.42 (3H, m), 1.46–1.64 (3H, m), 1.69–1.81 (2H, m), 1.86–2.00 (2H, m), 
3.07 (2H, d, 2JH,P = 21.7 Hz), 4.44 (1H, doublet of quintets, 2JH,H = 12.5 Hz, 3JH,F = 3JH,P = 8.1 Hz), 4.51–4.66 
(2H, m), 10.08 (1H, br s). 
13C NMR (75 MHz, CDCl3): δ 23.4 (s), 25.0 (s), 33.37 (d, 3JC,P = 2.5 Hz), 33.39 (d, 3JC,P = 5.0 Hz), 34.4 (d, 1JC,P 
= 140.8 Hz), 63.2 (qd, 2JC,F = 37.6 Hz, 2JC,P = 5.0 Hz), 78.2 (d, 2JC,P = 7.5 Hz), 122.9 (qd, 1JC,F = 277.4 Hz, 3JC,P = 
8.7 Hz), 167.6 (d, 2JC,P = 4.4 Hz). 
HRMS (ESI): m/z [M + H]+ calcd for C10H17F3O5P: 305.0766; found: 305.0762. 
Anal. calcd for C10H16F3O5P: C, 39.48; H, 5.30. Found: C, 39.44; H, 5.27%. 
 
2-[(Cycloheptyloxy)(2,2,2-trifluoroethoxy)phosphoryl]acetic Acid (4i) 
Colorless oil. 
IR (neat): 2935, 2864, 1732, 1290, 1234, 1174, 1095 cm-1. 
1H NMR (400 MHz, CDCl3): δ 1.34–1.49 (2H, m), 1.49–1.61 (4H, m), 1.61–1.73 (2H, m), 1.74–1.88 (2H, m), 
1.93–2.06 (2H, m), 3.06 (2H, d, 2JH,P = 22.0 Hz), 4.43 (1H, doublet of quintets, 2JH,H = 12.3 Hz, 3JH,F = 3JH,P = 
8.2 Hz), 4.59 (1H, doublet of quintets, 2JH,H = 12.3 Hz, 3JH,F = 3JH,P = 8.2 Hz), 4.71–4.82 (1H, m), 10.56 (1H, br 
s). 
13C NMR (75 MHz, CDCl3): δ 22.07 (s), 22.10 (s), 28.00 (s), 28.02 (s), 34.4 (d, 1JC,P = 141.4 Hz), 35.58 (d, 
3JC,P = 3.1 Hz), 35.63 (d, 3JC,P = 4.4 Hz), 63.3 (qd, 2JC,F = 37.7 Hz, 2JC,P = 4.7 Hz), 80.8 (d, 2JC,P = 7.5 Hz), 122.9 
(qd, 1JC,F = 277.5 Hz, 3JC,P = 8.7 Hz), 167.6 (d, 2JC,P = 4.4 Hz). 
HRMS (ESI): m/z [M + H]+ calcd for C11H19F3O5P: 319.0922; found: 319.0909. 
Anal. calcd for C11H18F3O5P: C, 41.52; H, 5.70. Found: C, 41.75; H, 5.53%. 
 
2-[(Cyclooctyloxy)(2,2,2-trifluoroethoxy)phosphoryl]acetic Acid (4j) 
Colorless oil. 
IR (neat): 2927, 1732, 1290, 1230, 1173, 1095, 1012 cm-1. 
1H NMR (400 MHz, CDCl3): δ 1.41–1.62 (8H, m), 1.64–1.76 (2H, m), 1.99–2.00 (4H, m), 3.05 (2H, d, 2JH,P = 
21.5 Hz), 4.43 (1H, doublet of quintets, 2JH,H = 12.2 Hz, 3JH,F = 3JH,P = 8.1 Hz), 4.60 (1H, doublet of quintets, 
2JH,H = 12.2 Hz, 3JH,F = 3JH,P = 8.4 Hz), 4.72–4.82 (1H, m), 9.30 (1H, br s). 
13C NMR (75 MHz, CDCl3): δ 22.1 (s), 25.0 (s), 27.2 (s), 32.6 (d, 3JC,P = 3.1 Hz), 32.7 (d, 3JC,P = 4.4 Hz), 34.4 
(d, 1JC,P = 140.8 Hz), 63.3 (qd, 2JC,F = 37.7 Hz, 2JC,P = 5.0 Hz), 80.9 (d, 2JC,P = 7.5 Hz), 122.9 (qd, 1JC,F = 277.5 
Hz, 3JC,P = 8.7 Hz), 167.6 (d, 2JC,P = 3.1 Hz). 
HRMS (ESI): m/z [M + H]+ calcd for C12H21F3O5P: 333.1079; found: 333.1082. 
Anal. calcd for C12H20F3O5P: C, 43.38; H, 6.07. Found: C, 43.28; H, 5.91%. 
 
3 Data, value and validation 
 
The result of the reaction of methyl bis(2,2,2-trifluoroethyl)phosphonoacetate (1) with σ-symmetrical 
secondary alcohols 2a–j and PLE-catalyzed kinetic resolution of the resultant racemic mixed 
phosphonoacetates rac-3a–j are summarized in Table 1 and Table 2, respectively. The biochemical 
stereoselectivity factor E was calculated according to E = ln[(1 − c)(1 − ee)] / ln[(1 − c)(1 + ee)], where c = 
ee / (ee + ee’), ee = enantiomeric excess of unreacted resolution substrates, and ee’ = enantiomeric 
excess of resolution products [10–12]. 
 
Table 1. 
Synthesis of racemic phosphonoacetates rac-3a–j. 
Entry ROH Time (h) Yield (%)  Entry ROH Time (h) Yield (%) 
1 2a 15 81 (rac-3a) a  6 2f 16 69 (rac-3f) a 
2 2b 15 74 (rac-3b) a  7 2g 2 75 (rac-3g) 
3 2c 16 71 (rac-3c) a  8 2h 3 80 (rac-3h) 
4 2d 15 79 (rac-3d) a  9 2i 3.5 71 (rac-3i) 
5 2e 15 66 (rac-3e) a  10 2j 3.5 72 (rac-3j) 
a Molecular Sieves (Type 3A) were used. 
 
Table 2. 
PLE-catalyzed kinetic resolution of phosphonoacetates rac-3a–j.  
Entry rac-3a–j Time 4a–j   3a–j   E e 
   Yield (%) Ee (%) a,b  Yield (%) Ee (%) b   
1 3a 1.5 h 61 64  39 99  22 
2 3b 50 min 37 72  59 28  8 
3 3c 3 h 28 76  72 22  9 
4 3d 48 h 56 76  44 >99  >37 
5 3e 54 h 48 82 c  49 82 c  26 
6 3f 13 d 42 54  56 40  5 
7 3g 45 min 80 17 d  20 68 d  3 
8 3h 1.5 h 84 11 d  14 42 d  2 
9 3i 55 min 55 40 d  45 51 d  4 
10 3j 40 min 32 70 d  67 32 d  8 
a HPLC analysis after methylation with TMSCHN2. 
b HPLC analysis (CHIRALPAK AD-H, n-hexane/2-propanol = 50/1, 1.0 mL/min, 220 nm). 
c HPLC analysis (CHIRALPAK IA, n-hexane/2-propanol = 100/1, 1.0 mL/min, 220 nm). 
d HPLC analysis (CHIRALPAK AS-H, n-hexane/2-propanol = 30/1, 1.0 mL/min, 220 nm). 
e Biochemical stereoselectivity factor [10–12]. 
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